Benzodiazepine Statistics
About one in fifty Americans misuses a benzodiazepine each year, and the class trails only opioids in prescription-overdose deaths. Here's who's affected, why young and older adults face different risks, and why recovery is the rule.
Battling addiction & ready for help?
Benzodiazepines by the Numbers
If you’re here because of your own benzodiazepine use or someone you love, the numbers can read like a wall of bad news. They aren’t.
Benzodiazepines are one of the most widely prescribed groups of psychiatric medications in the world, and tens of millions of prescriptions are written every year[1]. Most people who become dependent did nothing reckless. Roughly 2% of the U.S. population reports misusing a benzodiazepine in a given year, and physical dependence can build even at a normal prescribed dose[2].
What follows shows who uses these drugs, how the risk is shaped by age and other substances, and where the real danger lies. Behind every figure is a person, and the same numbers that map the problem also point straight at the way out.
Getting off benzodiazepines safely starts with a supervised taper, not going it alone. Call 988 if you're in danger.
What to do:
- Get a medically supervised taper instead of quitting on your own — after regular use, a slow, doctor-managed taper is the safe way off, and it spares you the dangerous reactions that abrupt stopping can trigger.
- Tell every prescriber about every substance you use — especially opioids and alcohol, so no one adds a drug that stacks the breathing risk.
- If someone mixed a benzodiazepine with opioids or alcohol and won’t wake up, call 911. Naloxone reverses opioids but not benzodiazepines — give it anyway if opioids may be involved, then call 911.
- About 2% of the U.S. population misuses a benzodiazepine in a given year, while fewer than 0.5% misuse z-drug sleep aids like Ambien[2].
- Young adults aged 18 to 25 have the highest rate of benzodiazepine misuse, and among young adults who use these drugs, 42.8% also misuse them[3].
- The deadly danger is combination, not the drug alone: benzodiazepine co-use is a significant predictor of opioid overdose, and benzodiazepines are rarely the sole cause of an overdose death[4].
How Many People Take Benzodiazepines
Scale explains everything that follows. Benzodiazepines and their close relatives are prescribed in enormous numbers in the United States, written for anxiety, panic, insomnia, seizures, muscle spasm, and alcohol withdrawal[1]. They sit under federal control as Schedule IV substances, the same legal tier that flags a recognized potential for dependence[5].
Prescribing Peaked in 2014 and Has Fallen Since
The prescribing curve has bent downward over the last decade. Drawing on national pharmacy dispensing data, researchers found that prescribing of benzodiazepine-type drugs reached its maximum in 2014, then declined year over year to roughly half of that peak by 2023[1]. Federal Medicare and Medicaid data showed the same downward trend[1].
As prescribing of these drugs fell, the non-benzodiazepine sedating antidepressant trazodone became the single most commonly prescribed sleep medication, by 2023 outnumbering zolpidem prescriptions more than two to one[1].
What this means: fewer benzodiazepine prescriptions is broadly good news, but it does not mean the risk is gone. Prescribing remains widespread, and a falling prescription count has been paired with a rising danger from illicit, non-prescribed pills[5].
Benzodiazepines Are Still Prescribed Heavily in Emergency Rooms
Emergency departments alone account for a striking volume. A national analysis of ER visits found 13,848,578 visits where a benzodiazepine was prescribed at discharge between 2012 and 2019[6]. That worked out to about 1.1% of all ER visits in 2012 and 0.9% in 2019, with no meaningful downward trend across those years[6].
The three benzodiazepines handed out most often at ER discharge were clear:
| Benzodiazepine | Brand name | Share of ER benzo prescriptions |
|---|---|---|
| Diazepam | Valium | 43.2%[6] |
| Alprazolam | Xanax | 23.9%[6] |
| Clonazepam | Klonopin | 15.2%[6] |
What this means: alprazolam (Xanax) carries one of the highest misuse potentials of any benzodiazepine, yet it was prescribed at nearly a quarter of these ER visits despite limited emergency indications[6]. The drug class people most associate with dependence is also one they’re most likely to be sent home with. As a class, sedatives sit under federal control precisely because of their misuse potential, and misuse most often looks like quiet dose escalation and early-refill requests, not dramatic abuse[7].
Benzodiazepine Addiction Statistics
This is the heart of the picture: how common use, misuse, and benzodiazepine use disorder actually are. The headline is straightforward. Exposure is widespread, outright misuse is a smaller slice, and the line into a use disorder is real but crossable in both directions.
About 1 in 50 Americans Misuses a Benzodiazepine Each Year
Using five years of national survey data (2015 to 2019), researchers estimated that only about 2% of the U.S. population misused a benzodiazepine in the past year, and fewer than 0.5% misused z-drugs like zolpidem (Ambien)[2]. A separate national analysis put past-month misuse of prescription tranquilizers at roughly 0.5% of U.S. adults, about 1.17 million people, in 2021 to 2023[8].
Those percentages matter because they cut against the fear. Most people prescribed a benzodiazepine are not misusing it, and even physical dependence, which can develop with regular use, is a different thing from compulsive misuse[2]. Dependence is a medical state the body settles into; misuse is a behavior. Confusing the two keeps people from asking for help they’d qualify for.
A Legitimate Prescription Can Still Lead to Later Misuse
The path from a valid prescription into trouble is documented. In a study tracking U.S. adults across decades to age 50, the picture by age 35 broke down like this[9]:
| Benzodiazepine history by age 35 | Share of adults |
|---|---|
| Never used or misused | 70.9%[9] |
| Medical use only | 11.3%[9] |
| Both medical use and misuse | 9.8%[9] |
| Misuse only | 14.1%[9] |
Adults who reported medical use only by age 35 still had more than double the odds of later benzodiazepine misuse (adjusted odds ratio 2.17) and higher odds of later prescription opioid misuse (adjusted odds ratio 1.40), compared with people who never used them[9]. More frequent medical use early on was tied to higher odds of substance use disorder symptoms in the 40s[9].
What this means: even careful, doctor-directed use deserves monitoring, because the medication itself carries a pull that can outlast the original reason for taking it[9]. That isn’t a reason for shame. It’s a reason to check in early, and to take any creeping misuse as a signal worth acting on.
Benzodiazepine prescribing in the U.S. peaked back in 2014 and had fallen to about half of that peak by 2023[1]. Yet the danger didn’t fall with it. Benzodiazepine-involved harm has been pushed increasingly by illicit, non-prescribed “designer” benzodiazepines of unknown strength, which is why a falling prescription count and a rising overdose risk can coexist[5].
Who Misuses Benzodiazepines, by Age and Sex
Benzodiazepine risk is not spread evenly. Two patterns stand out in the data: misuse concentrates among the young, while the harms of long-term use concentrate among the old.
Young Adults Have the Highest Misuse Rates
Drawing on a national survey of more than 114,000 people, researchers found that young adults aged 18 to 25 had the highest prevalence of past-year and past-month tranquilizer and sedative misuse of any age group[3]. Among young adults who used these drugs at all, 42.8% also misused them[3]. Misuse in this group traveled closely with other substance use, especially opioid misuse, and with mental-health distress[3].
Adolescents and young adults also receive these drugs in large numbers. In commercial-insurance data from 2008 to 2019, 1.8% of adolescents and 4.0% of young adults had at least one benzodiazepine dispensed, with benzodiazepine overdoses recorded for 0.04% and 0.05% of them, respectively[10]. State prescription-monitoring programs that required providers to check a database were tied to meaningful drops in dispensing (a 6.8% yearly reduction in adolescents and 12.5% in young adults), though those programs did not measurably cut overdoses in this group[10].
Certain groups within the adult population also show higher misuse. In national data from 2021 to 2023, bisexual adults were more than twice as likely to misuse prescription tranquilizers as heterosexual adults, often citing emotional coping as the reason[8]. Sexual-minority adults more broadly show elevated rates of benzodiazepine and opioid misuse[11].
Older Adults Carry the Risks of Long-Term Use
At the other end of the age range, the concern shifts from misuse to the harms of staying on these drugs for years. Chronic use of benzodiazepine-type drugs remains common among adults aged 65 and older, despite long-standing concerns about falls, fractures, and cognitive impairment in this group[12]. ER prescribing reflects it too: 15% of benzodiazepine prescriptions written at ER discharge went to patients 65 or older, a population that guidelines specifically warn against[6].
Older adults also obtain these drugs differently. In national survey data, adults 65 and older had the highest rate of getting tranquilizers and sedatives directly from a physician (38.2%) of any age group, and older adults using a physician source showed elevated rates of opioid misuse and serious psychological distress[13]. Chronic benzodiazepine exposure in this age range is linked to cognitive impairment, delirium, and a higher risk of falls and fractures[4].
What this means: the prevention message splits by age. For young adults, it’s about misuse and mixing with other drugs. For older adults, the safest move is often a slow, supervised taper off a drug they may have been taking for years, which research shows can be done safely[12].
The Benzodiazepine and Opioid Combination that Kills
Here is the single most important fact in the whole picture, and it isn’t a prevalence figure. Taken alone, benzodiazepines rarely cause a fatal overdose. The deaths come from combination. Each one slows breathing, and stacked with opioids or alcohol, the drive to breathe can shut down.
Naloxone Reverses Opioids, Not Benzodiazepines
One life-or-death distinction belongs at the front. Naloxone (Narcan) reverses an opioid overdose, but it does not reverse benzodiazepines. U.S. regulators consider the combination dangerous enough to carry a black-box warning, the strongest kind, against using opioids and benzodiazepines together[14]. In a mixed overdose, naloxone can still be life-saving by reversing the opioid part, so give it if opioids may be involved and call 911 regardless, because the benzodiazepine effect and the breathing risk can continue.
Co-Use Is Common and It Drives Overdose
The overlap with opioid treatment is large. Among people being treated for opioid use disorder, roughly 16% to 21% of patients on buprenorphine and 40% to 47% of those on methadone also use benzodiazepines[15]. That co-use is tied to higher rates of overdose, more ER visits, and worse odds of staying in treatment[15].
Reviews are blunt about the stakes: benzodiazepine co-use is a significant predictor of opioid overdose, and overdose deaths involving the combination have risen rapidly[4]. The same risk shows up in opioid-agonist treatment, where benzodiazepine co-prescription is linked to higher mortality[16].
The combination dominates the fatal-overdose data when benzodiazepines appear at all:
| Where benzodiazepines show up in overdose deaths | Figure |
|---|---|
| Opioid overdose deaths involving multiple substances (North Carolina, 2009–2018) | 53%[17] |
| Overdose deaths involving opioids and benzodiazepines together | 9.0% of all overdose deaths[17] |
| Prescription-depressant overdose deaths in the “prescription opioids + benzodiazepines” class (Massachusetts, 2000–2023) | 19.5%[18] |
| Prescription-depressant overdose deaths in the “fentanyl, cocaine, and benzodiazepines” class | 34.4%[18] |
In North Carolina, the overall polysubstance overdose death rate more than quadrupled, climbing from 2.9 to 12.1 per 100,000 people over a decade[17]. In a Massachusetts cohort of 8,665 prescription-depressant overdose deaths, fentanyl-involved classes came to dominate over time, swamping the older prescription-only patterns[18].
How the prescriptions are managed matters too. In a study of 529,053 patients already taking opioids and benzodiazepines together, overdose occurred for about 0.4% (1 in 231 patients), and the risk was 1.8 times higher on days when the two drugs were prescribed by multiple different prescribers rather than one[19].
Co-prescribing tends to start in identifiable situations: among long-term opioid patients, the strongest predictor of a new benzodiazepine being added was a high opioid dose above 150 morphine-milligram-equivalents a day[20].
What this means: if you take a benzodiazepine, the most protective thing you can do is tell every prescriber about every other substance you use, especially opioids and alcohol, and never combine them without a doctor managing it. The danger is real and it is also largely avoidable, and care coordinated under one prescriber appears safer than a regimen split across several[19].
Benzodiazepine Overdose and ER Visit Data
Even setting opioids aside, benzodiazepines carry measurable overdose risk, and the patterns reveal who’s most exposed.
Overdose Risk Among People Prescribed Benzodiazepines
A large cohort study of Medicare beneficiaries tracked what happened in the 30 days after a benzodiazepine prescription. Among new (incident) benzodiazepine users, 0.78% experienced a treated drug-overdose event within 30 days; among continuing users, 0.56% did[21]. Concurrent prescriptions sharply raised the risk: in older continuing users, a co-prescribed opioid was associated with about a 1.7-fold increase in overdose risk, with antipsychotics and antiepileptics adding further risk[21].
Benzodiazepines Define a Distinct Slice of ER Overdose Visits
Emergency department overdose data shows benzodiazepines clustering in an identifiable group. In an analysis of 120,706 ER overdose-related visits across 18 states in 2017 to 2018, one of the five distinct patient profiles was an older, predominantly female, benzodiazepine group that made up 8.0% of overdose visits[22]. Polysubstance toxicity, not a single drug, was the through-line in much of this ER burden[22].
That older-adult slice sits inside a bigger pattern. Adults 65 and older already account for 15% to 25% of all U.S. emergency department visits, and an estimated 10% of older-adult ER visits are medication-related[23]. Benzodiazepines, flagged as potentially inappropriate in this age group, are part of that medication risk.
What this means: the absolute overdose rate after a single prescription is low, but it climbs fast when benzodiazepines are layered with other depressants[21]. The risk is concentrated, identifiable, and a prescriber who knows the full medication list can manage it.
Benzodiazepine Use in Pregnancy
For anyone facing this decision, the numbers are more reassuring than the fear suggests. Benzodiazepine and z-drug dispensing during pregnancy has increased globally, alongside rising attention to its safety[24]. A systematic review and meta-analysis pooling several large studies found that gestational exposure was not associated with an increased risk of autism spectrum disorder in offspring, and was linked to only a marginally increased risk of ADHD (hazard ratio 1.07)[24].
The authors framed it plainly, and so should we: given the likelihood that the original studies were confounded by the underlying conditions these drugs treat, the findings should reassure women who need these medications for severe anxiety or insomnia during pregnancy[24].
What this means: pregnancy is a reason to manage benzodiazepine use carefully with a doctor, not a reason to panic or to stop abruptly on your own, which carries its own dangers. Decisions here belong in a conversation with a clinician who knows your situation.
Why Today’s Benzodiazepine Risk Is Rising
The most important shift in the data isn’t in the prescription numbers, which are falling. It’s in what’s being sold outside the pharmacy. Even as legitimate prescribing declined, misuse has stayed prevalent, increasingly driven by illicit “designer” benzodiazepines sold as pills of unknown strength[5]. These emerging substances, alongside others like xylazine, create real treatment challenges that the older prescription-focused picture didn’t[25].
A few realities define this newer risk:
- A street pill may not be what it looks like — non-prescribed designer benzodiazepines are a growing driver of benzodiazepine-involved harm, and their potency is unpredictable[5].
- There is an antidote, but not a street tool — some benzodiazepine overdoses can be reversed with flumazenil in a medical setting, alongside supportive care, but it is not something to rely on outside a hospital[7].
- Monitoring cut prescriptions, not deaths — state prescription-monitoring programs reduced benzodiazepine dispensing to young people but did not measurably lower their overdoses, a sign that the danger has shifted toward the illicit supply[10].
What this means: the safety story is no longer only about prescriptions. It’s about an increasingly contaminated, unregulated supply, which is one more reason that getting help through a medical setting, rather than self-managing, is the safe path.
What the Numbers Don’t Capture About Recovery
Statistics are good at counting prescriptions, misuse, and overdoses. They’re worse at capturing the quieter reality underneath: that benzodiazepine dependence is treatable and that most people who get proper help come off these drugs and stay off. A few patterns the data does support are worth holding onto.
- Dependence is not addiction — misuse touches a relatively small share of users (around 2% in a given year), while physical dependence is a far more common, expected adaptation to regular use[2].
- Tapering works, even for long-term and older users — a review of 30 studies covering roughly 11,000 older adults found that structured, gradual tapering was generally safe, with withdrawal symptoms typically mild and transient[12].
- Early action changes outcomes — clinicians are urged to routinely screen for benzodiazepine use, especially alongside opioids, because timely steps like education, gradual discontinuation, and therapy meaningfully reduce harm[4].
What this means: the most dangerous numbers here describe people who were using alone, mixing without medical oversight, or stopping cold turkey. The way around nearly all of it is the same: a supervised plan and support.
Getting Help for Benzodiazepine Dependence
Every statistic here is a count of people, and counts can hide the most important fact: a benzodiazepine use disorder is a treatable condition, and recovery is the expected outcome of a proper taper with support, not a long shot[12]. Behind the 2% who misuse[2], the 8% of ER overdose visits[22], and the deaths driven by mixing[4], there are people who got into treatment and got their lives back.
Whether you take Xanax, Klonopin, Ativan, Valium, or a sleep aid like Ambien, and whether you followed every instruction or things slipped out of your hands, the path is the same. The safe way off isn’t white-knuckling it alone; it’s a supervised detox or taper, where medication makes withdrawal far gentler than the agony you may be picturing, plus the counseling that makes it stick. To understand how dependence forms and what the safe path off looks like, start with how benzodiazepines work and why a taper is the way out.
If any of this lands, the next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.
Frequently asked questions
How common is benzodiazepine misuse in the United States?
It is far less common than benzodiazepine prescribing itself. Using national survey data from 2015 to 2019, researchers estimated that about 2% of the U.S. population misused a benzodiazepine in the past year, while fewer than 0.5% misused z-drug sleep aids like zolpidem[2]. A separate national analysis put past-month prescription tranquilizer misuse at roughly 0.5% of adults, about 1.17 million people, in 2021 to 2023[8]. It helps to separate two things: misuse is a behavior that touches a relatively small share of users, while physical dependence is a far more common and expected adaptation to regular use.
Who is most likely to misuse benzodiazepines?
Misuse concentrates in young adults. In a national survey of more than 114,000 people, adults aged 18 to 25 had the highest prevalence of past-year and past-month tranquilizer and sedative misuse, and among young adults who used these drugs, 42.8% also misused them[3]. Older adults face a different risk: chronic long-term use that raises the odds of falls, fractures, and cognitive problems[12]. In fact, 15% of benzodiazepines prescribed at ER discharge went to patients 65 or older, despite warnings against use in that group[6].
Are benzodiazepine prescriptions going up or down?
Down, overall. Using national pharmacy dispensing data, researchers found that prescribing of benzodiazepine-type drugs peaked in 2014 and then declined year over year to about half of that maximum by 2023, with federal Medicare and Medicaid data showing the same trend[1]. But a falling prescription count does not mean the danger is gone. Benzodiazepine-involved harm has been pushed increasingly by illicit, non-prescribed designer benzodiazepines of unknown strength, which is why fewer prescriptions and a rising overdose risk can happen at the same time[5].
Why are benzodiazepines so dangerous when combined with opioids?
Because each one slows breathing, and stacked together the drive to breathe can shut down. Taken alone, benzodiazepines rarely cause a fatal overdose; the deaths come from combination, and benzodiazepine co-use is a significant predictor of opioid overdose[4]. The danger is serious enough that U.S. regulators carry a black-box warning against using opioids and benzodiazepines together[14]. The overlap is large: roughly 16% to 21% of patients on buprenorphine and 40% to 47% of those on methadone also use benzodiazepines, which raises overdose and ER-visit rates[15]. Naloxone reverses the opioid part but not the benzodiazepine, so call 911 in any suspected overdose.
Is it safe to take benzodiazepines during pregnancy?
The data is more reassuring than the fear suggests, though this is a decision to make with a doctor. Benzodiazepine and z-drug use during pregnancy has increased globally, and a systematic review and meta-analysis found that gestational exposure was not associated with an increased risk of autism in offspring and was linked to only a marginally increased risk of ADHD[24]. The authors concluded the findings should reassure women who need these medications for severe anxiety or insomnia during pregnancy[24]. The key point is to manage use carefully with a clinician rather than stopping abruptly on your own, which carries its own risks.
Can people actually recover from benzodiazepine dependence?
Yes, and recovery is the expected outcome with proper care. The most dangerous numbers describe people using alone, mixing without medical oversight, or quitting cold turkey. A review of 30 studies covering roughly 11,000 older adults found that structured, gradual tapering was generally safe, with withdrawal symptoms typically mild and transient[12]. Clinicians are urged to screen for benzodiazepine use and act early, because timely steps like education, gradual discontinuation, and therapy meaningfully reduce harm[4]. You can find treatment and people who can help at /find-treatment-help/.
Get Treatment Help
If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.
Exclusive offer: 20% Off BetterHelp*Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.
- Fact-Checked
- Editor
